These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 2295294

  • 1. Oral administration of loxiglumide (CCK antagonist) inhibits postprandial gallbladder contraction without affecting gastric emptying.
    Corazziari E, Ricci R, Biliotti D, Bontempo I, De Medici A, Pallotta N, Torsoli A.
    Dig Dis Sci; 1990 Jan; 35(1):50-4. PubMed ID: 2295294
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dose-response effects of oral loxiglumide on postprandial gall-bladder emptying in man.
    Malesci A, De Fazio C, Festorazzi S, Bonato C, Valentini A, Tacconi M, Bekkering M, Giacovelli G, D'Amato M, Rovati LC.
    Arzneimittelforschung; 1992 Nov; 42(11):1359-62. PubMed ID: 1492852
    [Abstract] [Full Text] [Related]

  • 4. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
    Schmidt WE, Creutzfeldt W, Schleser A, Choudhury AR, Nustede R, Höcker M, Nitsche R, Sostmann H, Rovati LC, Fölsch UR.
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
    [Abstract] [Full Text] [Related]

  • 5. Role of cholecystokinin in regulation of gastrointestinal motor functions.
    Meyer BM, Werth BA, Beglinger C, Hildebrand P, Jansen JB, Zach D, Rovati LC, Stalder GA.
    Lancet; 1989 Jul 01; 2(8653):12-5. PubMed ID: 2567793
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of loxiglumide on gallbladder emptying in healthy volunteers.
    Niederau C, Heintges T, Rovati L, Strohmeyer G.
    Gastroenterology; 1989 Nov 01; 97(5):1331-6. PubMed ID: 2792664
    [Abstract] [Full Text] [Related]

  • 9. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide.
    Fried M, Erlacher U, Schwizer W, Löchner C, Koerfer J, Beglinger C, Jansen JB, Lamers CB, Harder F, Bischof-Delaloye A.
    Gastroenterology; 1991 Aug 01; 101(2):503-11. PubMed ID: 2065926
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of endogenous cholecystokinin on postprandial gallbladder refilling. Ultrasonographic study in healthy subjects and in gallstone patients.
    Cicala M, Corazziari E, Diacinti D, Badiali D, Torsoli A.
    Dig Dis Sci; 1995 Jan 01; 40(1):76-81. PubMed ID: 7821124
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The role of cholecystokinin and the cholinergic system in intravenous amino acid-induced gallbladder emptying.
    Gielkens HA, de Boer SY, Lam WF, Rovati LC, Lamers CB, Masclee AA.
    Eur J Gastroenterol Hepatol; 1997 Dec 01; 9(12):1227-31. PubMed ID: 9471030
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of a cholecystokinin receptor antagonist (loxiglumide) on gallbladder contractile function in guinea pigs.
    Tsubo K, Arai M, Omachi H, Mitamura K.
    J Gastroenterol; 1996 Aug 01; 31(4):578-81. PubMed ID: 8844481
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of somatostatin and loxiglumide on gallbladder motility.
    Lieverse RJ, Jansen JB, Jebbink MC, Masclee AA, Rovati LC, Lamers CB.
    Eur J Clin Pharmacol; 1995 Aug 01; 47(6):489-92. PubMed ID: 7768249
    [Abstract] [Full Text] [Related]

  • 19. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.
    Liddle RA, Gertz BJ, Kanayama S, Beccaria L, Coker LD, Turnbull TA, Morita ET.
    J Clin Invest; 1989 Oct 01; 84(4):1220-5. PubMed ID: 2794058
    [Abstract] [Full Text] [Related]

  • 20. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW.
    J Physiol Pharmacol; 1994 Dec 01; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.